Researchers assessed the effectiveness of a modified SUNTRAC to identify risk of skin cancer in solid organ transplant recipients.

Investigators presented initial results from the phase 3 RAMPART trial of adjuvant durvalumab monotherapy or combined with tremelimumab for resected primary renal cell carcinoma.

Increase seen in overall survival, especially among those with HER2+-positive cancers, with median increase of more than 10 months.

Oncology care gaps are more pronounced among rural populations, and in counties with higher levels of cancer mortality, health risks, and socioeconomic risks, researchers reported.

Exerkines, the molecular signals released through physical exertion, may be protective against radiation toxicities for patients with prostate cancer.